ARS Pharmaceuticals, Inc. (SPRY)
(Delayed Data from NSDQ)
$8.98 USD
+0.09 (1.01%)
Updated May 14, 2024 04:00 PM ET
After-Market: $8.98 0.00 (0.00%) 6:56 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.13 | -28.00% |
Earnings Summary
For their last quarter, ARS Pharmaceuticals, Inc. (SPRY) reported earnings of -$0.11 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for SPRY's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.13 per share, reflecting a year-over-year increase of 27.78%.
Earnings History
Price & Consensus
Zacks News for SPRY
Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why
SPRY: What are Zacks experts saying now?
Zacks Private Portfolio Services